Celulitis y erisipela

dc.creatorOlmos Olmos, Edgar
dc.creatorBonilla González, Diego Andrés
dc.date.accessioned2008-09-01 00:00:00
dc.date.accessioned2022-02-21T20:37:11Z
dc.date.accessioned2022-09-27T12:44:32Z
dc.date.available2008-09-01 00:00:00
dc.date.available2022-02-21T20:37:11Z
dc.date.available2022-09-27T12:44:32Z
dc.date.created2008-09-01 00:00:00
dc.date.created2022-02-21T20:37:11Z
dc.date.issued2008-09-01
dc.identifier0121-7372
dc.identifierhttps://repositorio.fucsalud.edu.co/handle/001/2406
dc.identifier2462-991X
dc.identifierhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/509
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3596949
dc.languagespa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.relationOlmos E, Bonilla CE. Infección por Streptococcus y Staphylococcus en dermatología. En Olmos E: Texto de dermatología 25 años Hospital de San José. Bogotá: Sociedad de Cirugía de Bogotá; 2007, p. 187-203.
dc.relationCamilleri MJ, Daniel Su WP. Panniculitis. En: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith LA, Katz S: Fitzpatrick's dermatology in general medicine, 6th ed; 2003. p.1275-8.
dc.relationSwartz MN, Pastemack MS. Skin and soft tissue infections. En Mandell GL, Bennett JE, Dolin R: Principles and practice of infectious disease. 6th ed. Philadelphia: Churchill Livingstone; 2005, p.1172-84.
dc.relationStevens DL. Cellulitis, pyoderma, abscesses and other skin and subcutaneous infections. En: Cohen J, Powderly WG: Infectous diseases. 2nd ed. Philadelphia: Mosby Elsevier; 2004. p. 133-55.
dc.relationBonnetblanc JM, Bédane C. Erysipelas: recognition and management. Am J Clin Dermatol. 2003;4(3):157-63.
dc.relationSwartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004 Feb 26;350(9):904-12.
dc.relationGordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005 Nov 3;353(18):1945-54.
dc.relationDupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grob JJ, Bastuji-Garin S. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999 Jun 12;318(7198):1591-4.
dc.relationWoo PC, Lum PN, Wong SS, Cheng VC, Yuen KY. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):294-7.
dc.relationVinh DC, Embil JM. Rapidly progressive soft tissue infections. Lancet Infect Dis. 2005 Aug;5(8):501-13.
dc.relationLazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005 Dec;51(5):383-9.
dc.relationCelestin R, Brown J, Kihiczak G, Schwartz RA. Erysipelas: a common potentially dangerous infection. Acta Dermatovenerol Alp Panonica Adriat. 2007 S ep;16(3):123-7.
dc.relationBisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996 Jan 25;334(4):240-5.
dc.relationWeedon D. Cutaneous infections and infestation-histoed. logical patterns. En: Weedon D: Skin pathology. Philadelphia: Churchill Livingstone; 2002. p.613-5.
dc.relationWeedon D. Bacterial and rickettsial infections. En: Weedon D: Skin pathology. 2nd. d. Philadelphia: Churchill Livingstone; 2002. p. 617-47.
dc.relationStevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005 Nov 15;41(10):1373-406.
dc.relationParish LC, Jungkind DL. Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime. Am J Med. 1993 Mar 22 ;94(3A): 166S-173 S.
dc.relationHepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intem Med. 2004 Aug 9-23;164(15):1669-74.
dc.relationZeglaoui F, Dziri C, Mokhtar I, Ezzine N, Kharfi M, Zghal M, Fazaa B, Kamoun MR. Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: randomized controlled study. J Eur Acad Dermatol Venereol. 2004 Jul;18(4):426-8.
dc.relationLipsky BA, BerendtAR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS; Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004 Oct 1;39(7):885-910.
dc.relationXagena Medicina [página en Internet] Milano: Xagena; c2005. [citado 9 Jun 2008]. FDA approves Merrem for complicated skin and skin structure infections; [aprox. 1 pantalla]. Disponible en: http://www.xagenalt/news/medicinenews_netnews/c64e7fcbl7df2cd481732022aebb215a.html.
dc.relationBergkvist PI, Sjdbeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebocontrolled study. Scand J Infect Dis. 1997;29(4):377-82.
dc.relationSjóblom AC, Eriksson B, Jorup-Rünstróm C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infection. 1993 Nov-Dec ;21 (6):390-3 .
dc.relationKasserroller R. Sodium selenite as prophylaxis against erysipelas in secondary lymphedema. Anticancer Res. 1998 May-Jun; 18(3C):2227-30.
dc.relationMcNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, Baddour LM. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007 Apr 9;167(7):709-15.
dc.relationNLN Medical Advisory Committee. Position statement of the National Lymphedema Network [monografía en Internet]. Oakland: National Lymphedema Network; 2005. [actualizado 8 Oct 2006; citado 9 Jun 2008]. Disponible en:http://www.lymphnet.org/pdfDocs/nIntreatment.pdf.
dc.relationKrasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance. Dermatology. 2006;212(1):31-5.
dc.relationhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/509/552
dc.relationNúm. 3 , Año 2008 : Julio – Septiembre
dc.relation175
dc.relation3
dc.relation167
dc.relation17
dc.relationRevista Repertorio de Medicina y Cirugía
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsFundación Universitaria de Ciencias de la Salud FUCS - 0
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/509
dc.subjectcelulitis
dc.subjecterisipela
dc.subjecterisipela ampollosa
dc.subjectcomplicaciones
dc.subjecttratamiento
dc.subjectantibiótico
dc.subjectfactores predisponentes
dc.subjectrecurrencia
dc.subjectcellulitis
dc.subjecterysipelas
dc.subjecterysipelas bullosa
dc.subjectcomplications
dc.subjecttreatment
dc.subjectantibiotic
dc.subjectpredisposing factors
dc.subjectrecurrence
dc.titleCelulitis y erisipela
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución